Single-dose euglycemic clamp study demonstrating pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and US- and EU-approved versions of insulin aspart in subjects with type 1 diabetes.

Christoph Kapitza,Leszek Nosek,Wolfgang Schmider,L. Teichert,Irene Nowotny

Single-dose euglycemic clamp study demonstrating pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and US- and EU-approved versions of insulin aspart in subjects with type 1 diabetes.

2019

Christoph Kapitza
Leszek Nosek
Wolfgang Schmider
L. Teichert
Irene Nowotny

Background: The objective of this study was to demonstrate the pharmacokinetic and pharmacodynamic similarity among SAR341402 insulin aspart biosimilar/follow-on product, United States-sourced insu...

Keywords:

Pharmacodynamics
Clamp
Endocrinology
Medicine
Insulin aspart
Internal medicine
Diabetes mellitus
Pharmacokinetics
Type 1 diabetes
Biosimilar
phase i study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations